Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Debt Ratio (2016 - 2024)

Historic Debt Ratio for Protalix BioTherapeutics (PLX) over the last 11 years, with Q2 2024 value amounting to 0.22.

  • Protalix BioTherapeutics' Debt Ratio changed N/A to 0.22 in Q2 2024 from the same period last year, while for Jun 2024 it was 0.22, marking a year-over-year change of. This contributed to the annual value of 0.24 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q2 2024, Protalix BioTherapeutics' Debt Ratio is 0.22.
  • In the past 5 years, Protalix BioTherapeutics' Debt Ratio ranged from a high of 0.8 in Q4 2020 and a low of 0.04 during Q3 2021
  • Moreover, its 4-year median value for Debt Ratio was 0.24 (2023), whereas its average is 0.35.